Therefore, MLK3 SUMOylation not only participates in ischemic cerebral damage but may also be involved in other pathogenesis mediated by MLK3 activation, such as Alzheimer’s disease and oxidative stress injury. The gene discussed is MAP3K11; the disease is early-onset autosomal dominant Alzheimer disease.